| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.038 | 0.8 |